Obesity in pregnancy: Data from the hyperglycemia and adverse pregnancy outcome (HAPO) study

Harold David McIntyre; Lynn P. Lowe; Alan R. Dyer; Boyd E. Metzger

doi:10.1007/978-3-642-25023-1_17

Obesity in pregnancy: Data from the hyperglycemia and adverse pregnancy outcome (HAPO) study

Harold David McIntyre^*, Lynn P. Lowe, Alan R. Dyer, Boyd E. Metzger

^*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceeding › Chapter

5 Scopus citations

Abstract

The Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study has provided an opportunity to assess the relative associations of maternal glycemia measured at an oral glucose tolerance test (mean 28 weeks gestation) and maternal body mass index with a range of adverse pregnancy outcomes, without many of the potential confounding factors seen in previous studies. The HAPO study confirmed independently significant associations between maternal BMI and birthweight >90th centile, frequency of primary cesarean section, neonatal hypoglycemia, neonatal hyperinsulinemia, preeclampsia, and neonatal adiposity. The combination of maternal obesity and gestational diabetes was associated with higher frequencies of adverse outcomes than either variable in isolation.

Original language	English (US)
Title of host publication	Maternal Obesity and Pregnancy
Publisher	Springer-Verlag Berlin Heidelberg
Pages	271-281
Number of pages	11
Volume	9783642250231
ISBN (Electronic)	9783642250231
ISBN (Print)	364225022X, 9783642250224
DOIs	https://doi.org/10.1007/978-3-642-25023-1_17
State	Published - Oct 1 2012

ASJC Scopus subject areas

General Medicine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/978-3-642-25023-1_17

Cite this

@inbook{c0ddafba5e8045a192b8399a72627bfb,

title = "Obesity in pregnancy: Data from the hyperglycemia and adverse pregnancy outcome (HAPO) study",

abstract = "The Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study has provided an opportunity to assess the relative associations of maternal glycemia measured at an oral glucose tolerance test (mean 28 weeks gestation) and maternal body mass index with a range of adverse pregnancy outcomes, without many of the potential confounding factors seen in previous studies. The HAPO study confirmed independently significant associations between maternal BMI and birthweight >90th centile, frequency of primary cesarean section, neonatal hypoglycemia, neonatal hyperinsulinemia, preeclampsia, and neonatal adiposity. The combination of maternal obesity and gestational diabetes was associated with higher frequencies of adverse outcomes than either variable in isolation.",

author = "McIntyre, {Harold David} and Lowe, {Lynn P.} and Dyer, {Alan R.} and Metzger, {Boyd E.}",

note = "Publisher Copyright: {\textcopyright} 2012 Springer-Verlag Berlin Heidelberg. All rights are reserved.",

year = "2012",

month = oct,

day = "1",

doi = "10.1007/978-3-642-25023-1_17",

language = "English (US)",

isbn = "364225022X",

volume = "9783642250231",

pages = "271--281",

booktitle = "Maternal Obesity and Pregnancy",

publisher = "Springer-Verlag Berlin Heidelberg",

}

TY - CHAP

T1 - Obesity in pregnancy

T2 - Data from the hyperglycemia and adverse pregnancy outcome (HAPO) study

AU - McIntyre, Harold David

AU - Lowe, Lynn P.

AU - Dyer, Alan R.

AU - Metzger, Boyd E.

PY - 2012/10/1

Y1 - 2012/10/1

N2 - The Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study has provided an opportunity to assess the relative associations of maternal glycemia measured at an oral glucose tolerance test (mean 28 weeks gestation) and maternal body mass index with a range of adverse pregnancy outcomes, without many of the potential confounding factors seen in previous studies. The HAPO study confirmed independently significant associations between maternal BMI and birthweight >90th centile, frequency of primary cesarean section, neonatal hypoglycemia, neonatal hyperinsulinemia, preeclampsia, and neonatal adiposity. The combination of maternal obesity and gestational diabetes was associated with higher frequencies of adverse outcomes than either variable in isolation.

AB - The Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study has provided an opportunity to assess the relative associations of maternal glycemia measured at an oral glucose tolerance test (mean 28 weeks gestation) and maternal body mass index with a range of adverse pregnancy outcomes, without many of the potential confounding factors seen in previous studies. The HAPO study confirmed independently significant associations between maternal BMI and birthweight >90th centile, frequency of primary cesarean section, neonatal hypoglycemia, neonatal hyperinsulinemia, preeclampsia, and neonatal adiposity. The combination of maternal obesity and gestational diabetes was associated with higher frequencies of adverse outcomes than either variable in isolation.

UR - http://www.scopus.com/inward/record.url?scp=84949176207&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84949176207&partnerID=8YFLogxK

U2 - 10.1007/978-3-642-25023-1_17

DO - 10.1007/978-3-642-25023-1_17

M3 - Chapter

AN - SCOPUS:84949176207

SN - 364225022X

SN - 9783642250224

VL - 9783642250231

SP - 271

EP - 281

BT - Maternal Obesity and Pregnancy

PB - Springer-Verlag Berlin Heidelberg

ER -

Obesity in pregnancy: Data from the hyperglycemia and adverse pregnancy outcome (HAPO) study

Abstract

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this